Leakage of macromolecules from guinea-pig tracheobronchial microcirculation. Effects of allergen, leukotrienes, tachykinins, and anti-asthma drugs.
The tracheobronchial mucosa of anaesthetized guinea-pigs (normal or sensitized with ovalbumin to produce IgE and IgG antibodies) was superfused (0.02 ml min-1, 5 min) with saline, mediators, and (in sensitized animals) ovalbumin via a catheter atraumatically introduced orally. The intravascular blood pool and amount of macromolecules in excised trachea and adjoining main bronchi were quantified by measuring erythrocytes, that had been labelled in vivo with 99Tcm, and analysing for FITC-dextran, MW = 70,000, that had been given i.v. Extravasation of macromolecules was determined as the analysed total content minus the calculated intravascular content of FITC-dextran. Capsaicin 0.1 nmol extravasated 223 micrograms of FITC-dextran per g wet weight of airway tissue (P less than 0.001). Substance P 0.1 nmol, 41 micrograms g-1 (P greater than 0.05); substance P 0.3 nmol, 142 micrograms g-1 (P less than 0.001); eledoisine 0.1 nmol, 101 micrograms g-1 (P less than 0.01); ovalbumin 0.1 microgram, 179 micrograms g-1 (P less than 0.001); LTC4 0.2 pmol, 180 micrograms g-1 (P less than 0.001); LTD4 0.2 pmol 223 micrograms ml-1 (P less than 0.001). Bronchi and trachea were similarly affected by these agents. Prior superfusion (0.02 ml min-1, 30 min) with terbutaline 0.06 nmol, enprofylline 12 nmol, or lidocaine 6 nmol significantly reduced the effect of capsaicin. Enprofylline also reduced significantly the effect of LTC4. The degree of extravasation in this study was smaller than could be detected by changes in tissue wet to dry weight ratios. The present data support the view that tracheobronchial vascular permeability to macromolecules is subject to physiological and pharmacological control.
Persson
C G
CG
Erjefält
I
I
Andersson
P
P
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000485:Allergens / Q000494:pharmacology*; D000818:Animals; D001980:Bronchi / Q000098:blood supply* / Q000276:immunology; D006168:Guinea Pigs; D006969:Hypersensitivity, Immediate; D046911:Macromolecular Substances; D008833:Microcirculation / Q000187:drug effects*; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D013189:SRS-A / Q000494:pharmacology*; D015320:Tachykinins; D014132:Trachea / Q000098:blood supply* / Q000276:immunology
D000318:Adrenergic beta-Agonists; D000485:Allergens; D046911:Macromolecular Substances; D009419:Nerve Tissue Proteins; D013189:SRS-A; D015320:Tachykinins